|
1
|
Warburg O: On the origin of cancer cells.
Science. 123:309–314. 1956. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mashima T, Seimiya H and Tsuruo T: De novo
fatty-acid synthesis and related pathways as molecular targets for
cancer therapy. Br J Cancer. 100:1369–1372. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Furuta E, Okuda H, Kobayashi A and Watabe
K: Metabolic genes in cancer: their roles in tumor progression and
clinical implications. Biochim Biophys Acta. 1805:141–152.
2010.PubMed/NCBI
|
|
4
|
Wellen KE, Hatzivassiliou G, Sachdeva UM,
Bui TV, Cross JR and Thompson CB: ATP-citrate lyase links cellular
metabolism to histone acetylation. Science. 324:1076–1080. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hatzivassiliou G, Zhao F, Bauer DE, et al:
ATP citrate lyase inhibition can suppress tumor cell growth. Cancer
Cell. 8:311–321. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bauer DE, Hatzivassiliou G, Zhao F,
Andreadis C and Thompson CB: ATP citrate lyase is an important
component of cell growth and transformation. Oncogene.
24:6314–6322. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Migita T, Narita T, Nomura K, et al: ATP
citrate lyase: activation and therapeutic implications in non-small
cell lung cancer. Cancer Res. 68:8547–8554. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Beckner ME, Fellows-Mayle W, Zhang Z, et
al: Identification of ATP citrate lyase as a positive regulator of
glycolytic function in glioblastomas. Int J Cancer. 126:2282–2295.
2010.PubMed/NCBI
|
|
9
|
Zhou W, Han WF, Landree LE, et al: Fatty
acid synthase inhibition activates AMP-activated protein kinase in
SKOV3 human ovarian cancer cells. Cancer Res. 67:2964–2971. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Iorio E, Mezzanzanica D, Alberti P, et al:
Alterations of choline phospholipid metabolism in ovarian tumor
progression. Cancer Res. 65:9369–9376. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kuhajda FP: Fatty-acid synthase and human
cancer: new perspectives on its role in tumor biology. Nutrition.
16:202–208. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ookhtens M, Kannan R, Lyon I and Baker N:
Liver and adipose tissue contributions to newly formed fatty acids
in an ascites tumor. Am J Physiol. 247:R146–R153. 1984.PubMed/NCBI
|
|
14
|
Swinnen JV, Brusselmans K and Verhoeven G:
Increassed lipogenesis in cancer cells: new players, novel target.
Curr Opin Clin Nutr Metab Care. 9:358–365. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pelicano H, Martin DS, Xu RH and Huang P:
Glycolysis inhibition for anticancer treatment. Oncogene.
25:4633–4646. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Luo J, Manning BD and Cantley LC:
Targeting the PI3K-Akt pathway in human cancer: rationale and
promise. Cancer Cell. 4:257–262. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mazzoletti M and Broggini M: PI3K/AKT/mTOR
inhibitors in ovarian cancer. Curr Med Chem. 17:4433–4447. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fresno Vara JA, Casado E, de Castro J,
Cejas P, Belda-Iniesta C and Gonzalez-Baron M: PI3K/Akt signalling
pathway and cancer. Cancer Treat Rev. 30:193–204. 2004.PubMed/NCBI
|
|
19
|
Bababeygy SR, Polevaya NV, Youssef S, et
al: HMG-CoA reductase inhibition causes increased necrosis and
apoptosis in an in vivo mouse glioblastoma multiforme model.
Anticancer Res. 29:4901–4908. 2009.PubMed/NCBI
|
|
20
|
Relja B, Meder F, Wilhelm K, Henrich D,
Marzi I and Lehnert M: Simvastatin inhibits cell growth and induces
apoptosis and G0/G1 cell cycle arrest in hepatic cancer cells. Int
J Mol Med. 26:735–741. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Walter K, Hong SM, Nyhan S, et al: Serum
fatty acid synthase as a marker of pancreatic neoplasia. Cancer
Epidemiol Biomarkers Prev. 18:2380–2385. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Migita T, Ruiz S, Fornari A, et al: Fatty
acid synthase: a metabolic enzyme and candidate oncogene in
prostate cancer. J Natl Cancer Inst. 101:519–532. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hilvo M, Denkert C, Lehtinen L, et al:
Novel theranostic opportunities offered by characterization of
altered membrane lipid metabolism in breast cancer progression.
Cancer Res. 71:3236–3245. 2011. View Article : Google Scholar
|
|
24
|
Wang C, Xu C, Sun M, Luo D, Liao DF and
Cao D: Acetyl-CoA carboxylase-alpha inhibitor TOFA induces human
cancer cell apoptosis. Biochem Biophys Res Commun. 385:302–306.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Turyn J, Schlichtholz B, Dettlaff-Pokora
A, et al: Increased activity of glycerol 3-phosphate dehydrogenase
and other lipogenic enzymes in human bladder cancer. Horm Metab
Res. 35:565–569. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Szutowicz A, Kwiatkowski J and Angielski
S: Lipogenetic and glycolytic enzyme activities in carcinoma and
nonmalignant diseases of the human breast. Br J Cancer. 39:681–687.
1979. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yahagi N, Shimano H, Hasegawa K, et al:
Co-ordinate activation of lipogenic enzymes in hepatocellular
carcinoma. Eur J Cancer. 41:1316–1322. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Varis A, Wolf M, Monni O, et al: Targets
of gene amplification and overexpression at 17q in gastric cancer.
Cancer Res. 62:2625–2629. 2002.PubMed/NCBI
|
|
29
|
Moon YA, Lee JJ, Park SW, Ahn YH and Kim
KS: The roles of sterol regulatory element-binding proteins in the
transactivation of the rat ATP citrate-lyase promoter. J Biol Chem.
275:30280–30286. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sato R, Okamoto A, Inoue J, et al:
Transcriptional regulation of the ATP citrate-lyase gene by sterol
regulatory element-binding proteins. J Biol Chem. 275:12497–12502.
2000. View Article : Google Scholar : PubMed/NCBI
|
